A Clinical Risk Prediction Tool for 6-Month Mortality After Dialysis Initiation Among Older Adults

医学 透析 逻辑回归 内科学 心力衰竭 肾功能 死亡率 弗雷明翰风险评分 腹膜透析 队列 重症监护医学 急诊医学 疾病
作者
James Wick,Tanvir Chowdhury Turin,Peter Faris,Jennifer M. MacRae,Robert G. Weaver,Marcello Tonelli,Braden Manns,Brenda R. Hemmelgarn
出处
期刊:American Journal of Kidney Diseases [Elsevier]
卷期号:69 (5): 568-575 被引量:62
标识
DOI:10.1053/j.ajkd.2016.08.035
摘要

Information on an individual's risk for death following dialysis therapy initiation may inform the decision to initiate maintenance dialysis for older adults. We derived and validated a clinical risk prediction tool for all-cause mortality among older adults during the first 6 months of maintenance dialysis treatment.Prediction model using retrospective administrative and clinical data.We linked administrative and clinical data to define a cohort of 2,199 older adults (age ≥ 65 years) in Alberta, Canada, who initiated maintenance dialysis therapy (excluding acute kidney injury) in May 2003 to March 2012.Demographics, laboratory data, comorbid conditions, and measures of health system use.All-cause mortality within 6 months of dialysis therapy initiation.Predicted mortality by logistic regression with 10-fold cross-validation.375 (17.1%) older adults died within 6 months. We developed a 19-point risk score for 6-month mortality that included age 80 years or older (2 points), glomerular filtration rate of 10 to 14.9mL/min/1.73m2 (1 point) or ≥15mL/min/1.73m2 (3 points), atrial fibrillation (2 points), lymphoma (5 points), congestive heart failure (2 points), hospitalization in the prior 6 months (2 points), and metastatic cancer (3 points). Model discrimination (C statistic = 0.72) and calibration (Hosmer-Lemeshow χ2=10.36; P=0.2) were reasonable. As examples, a score < 5 equated to <25% of individuals dying in 6 months, whereas a score > 12 predicted that more than half the individuals would die in the first 6 months.The tool has not been externally validated; thus, generalizability cannot be assessed.We used readily available clinical information to derive and internally validate a 7-variable tool to predict early mortality among older adults after dialysis therapy initiation. Following successful external validation, the tool may be useful as a clinical decision tool to aid decision making for older adults with kidney failure.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
橘寄完成签到,获得积分10
刚刚
请叫我风吹麦浪应助mito采纳,获得10
1秒前
Smallhei完成签到,获得积分10
1秒前
2秒前
111111111完成签到,获得积分20
2秒前
3秒前
阿牛完成签到,获得积分20
4秒前
5秒前
111111111发布了新的文献求助10
6秒前
6秒前
6秒前
龙华之士完成签到,获得积分10
7秒前
机智的青槐完成签到 ,获得积分10
8秒前
阿牛发布了新的文献求助10
8秒前
虚拟的凡波完成签到,获得积分10
8秒前
pinging应助离线采纳,获得10
8秒前
在水一方应助甜甜晓露采纳,获得10
8秒前
spurs17完成签到,获得积分10
9秒前
黎乐乐完成签到 ,获得积分10
9秒前
miao完成签到,获得积分10
9秒前
10秒前
小郭完成签到 ,获得积分10
10秒前
龙华之士发布了新的文献求助10
10秒前
smile完成签到,获得积分10
10秒前
斯文败类应助动听导师采纳,获得10
11秒前
11秒前
复杂曼梅发布了新的文献求助10
11秒前
迷糊完成签到,获得积分10
12秒前
12秒前
汉堡包应助Rrr采纳,获得10
13秒前
新的心跳发布了新的文献求助10
13秒前
NN应助科研通管家采纳,获得10
14秒前
科研通AI2S应助科研通管家采纳,获得10
15秒前
共享精神应助科研通管家采纳,获得10
15秒前
今后应助科研通管家采纳,获得30
15秒前
shouyu29应助科研通管家采纳,获得10
15秒前
英俊的铭应助科研通管家采纳,获得10
15秒前
深情安青应助科研通管家采纳,获得10
15秒前
CodeCraft应助科研通管家采纳,获得10
15秒前
完美世界应助科研通管家采纳,获得60
15秒前
高分求助中
Continuum Thermodynamics and Material Modelling 3000
Production Logging: Theoretical and Interpretive Elements 2700
Social media impact on athlete mental health: #RealityCheck 1020
Ensartinib (Ensacove) for Non-Small Cell Lung Cancer 1000
Unseen Mendieta: The Unpublished Works of Ana Mendieta 1000
Bacterial collagenases and their clinical applications 800
El viaje de una vida: Memorias de María Lecea 800
热门求助领域 (近24小时)
化学 材料科学 生物 医学 工程类 有机化学 生物化学 物理 纳米技术 计算机科学 内科学 化学工程 复合材料 基因 遗传学 物理化学 催化作用 量子力学 光电子学 冶金
热门帖子
关注 科研通微信公众号,转发送积分 3527928
求助须知:如何正确求助?哪些是违规求助? 3108040
关于积分的说明 9287614
捐赠科研通 2805836
什么是DOI,文献DOI怎么找? 1540070
邀请新用户注册赠送积分活动 716904
科研通“疑难数据库(出版商)”最低求助积分说明 709808